Počet záznamov: 1

busulfán

SYS		d002066
LBL		00000nx--j22000003--45--
005		20240119200858.3
100		$a 19990101csloy0103----ba0
152		$b mesh
250		$a busulfán $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo
330	1-	$a An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. $8 eng
450		$a Busulphan $5 e $8 eng
550		$3 sllk_un_auth*d000477 $Y Alkylating Agents $5 P $a činidlá alkylačné
550		$3 sllk_un_auth*d018906 $Y Antineoplastic Agents, Alkylating $5 P $a antineoplastiká alkylačné
550		$3 sllk_un_auth*d007166 $Y Immunosuppressive Agents $5 P $a imunosupresíva
550		$3 sllk_un_auth*d019653 $Y Myeloablative Agonists $5 P $a agonisty myeloablácie
686		$a D02.033.455.125.125
686		$a D02.455.326.146.100.050.500.100
686		$a D02.886.645.600.055.050.510.100
750		$a Busulfan $8 eng
801	-0	$a US $b DNLM $c 19990101
801	-2	$a SK $b BA006 $c 20070706
980		$x M

Počet záznamov: 1